NPSP558
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for NPSP558, covering 2015-03-06 to 2019-08-06. Get the full timeline:
Most recent: Clinical Trial Update: A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE) [Phase 3]